Anemia and transfusions in geriatric patients: A time for evaluation

Hematology

Volumn 15, Issue 2, 2010, Pages 116-121

  Beyer, I ^a   Compte N ^b   Busuioc, A ^c   Cappelle, S ^b   Lanoy, C ^c   Cytryn, E ^c  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Anemia; Elderly; Transfusion

Indexed keywords

CYANOCOBALAMIN; ERYTHROPOIETIN; FOLIC ACID; HEMOJUVELIN; LENALIDOMIDE;

5Q- SYNDROME; ANEMIA; BLOOD TRANSFUSION REACTION; CLINICAL TRIAL; CYANOCOBALAMIN DEFICIENCY; DRUG EFFICACY; DRUG MECHANISM; ERYTHROCYTE TRANSFUSION; FOLIC ACID DEFICIENCY; GERIATRIC CARE; HUMAN; IRON DEFICIENCY ANEMIA; LUNG INJURY; MACROCYTIC ANEMIA; NEUTROPENIA; NORMOCHROMIC NORMOCYTIC ANEMIA; NUTRITIONAL DEFICIENCY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK BENEFIT ANALYSIS; THERAPY EFFECT; THROMBOCYTOPENIA; TREATMENT INDICATION; VITAMIN SUPPLEMENTATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANEMIA; BLOOD TRANSFUSION; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEALTH SERVICES FOR THE AGED; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MALNUTRITION; MYELODYSPLASTIC SYNDROMES; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77952216612     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453310X12583347010052     Document Type: Review

References (44)

1. WHO Tech Rep Ser 1968; 405: 1-401.
2. Natvig K. Studies on hemoglobin levels in Norway. V. Hemoglobin concentrations and hematocrit in men aged 15-21 years. Acta Med Scand 1966; 180: 613-620.
3. Kilpatrick GS, Hardisty RM. The prevalence of anemia in the community. A survey random sample of the population. BMJ 1961; 1: 778-782.
4. De Leeuw NKM, Lowenstein L, Hsieh Y. Iron deficiency and hydremia in normal pregnancy. Medicine (Baltimore) 1966; 455: 291-315.
5. Sturgeon P. Study of iron requirements in infants. III. Influence of supplemental iron during normal pregnancy on mother and infant. Brit J Haematol 1959; 5: 31-44.
6. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 2006; 107: 1747-1750.
7. Nilsson-Ehle H, Jagenburg R, Landahl S, Svanborg A. Blood haemoglobin declines in the elderly: implications for reference intervals from age 70 to 88. Eur J Haematol 2000; 65: 297-305.
8. Eisenstaedt R, Penninx B, Woodman R. Anemia in the elderly: current understanding and emerging concepts. Blood Rev 2006; 20: 213-226.
9. Beghé C, Wilson A, Ershler WB. Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature. Am J Med 2004; 116: 3S-10S.
10. Steensma DP, Tefferi A. Anemia in the elderly: how should we define it, when does it matter, and what can be done? Mayo Clin Proc 2007; 82: 958-966.
11. Patel KV. Epidemiology of anemia in older Adults. Semin Hematol 2008; 45: 210-217.
12. Balducci L. Epidemiology of anemia in the elderly: information on diagnostic evaluation. J Am Geriatr Soc 2003; 51: S2-S9.
13. Carmel R. Nutritional anemias and the elderly. Blood Rev 2001; 15: 9-18.
14. Van Puyvelde K, Cytryn E, Mets T, Beyer I. Anemia in the elderly. Acta Clin Belgica 2009; in press.
15. Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. . Clin J Am Soc Nephrol 2006; 1: S4-S8.
16. Punnonen K, Irjala K, Rajamäki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997; 89: 1052.
17. Fenaux P, Kelaidi C. Treatment of the 5q-syndrome. Hematology 2006; 81: 193-198.
18. Artz AS. Anemia and the frail elderly. Semin Hematol 2008; 45: 261-266.
19. Rossi DJ, Bryder1 D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007; 447: 725-729.
20. Gazit R, Weissman IL, Rossi DJ. Hematopoietic stem cells and the aging hematopoietic system. Semin Hematol 2008; 45: 218-224.
21. Ershler WB. Biological interactions of aging and anemia: a focus on cytokines. J Am Geriatr Soc 2003; 51: S18-S21.
22. Weiss G, Goodnough LT. Anemia of chronic disease. NEJM 2005; 352: 1011-1023.
23. Carson JL, Duff A, Poses RM et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348: 1055-1060.
24. Chaves PHM, AsharB, Guralnik JM, Fried LP. Looking at the relationship between hemoglobin concentrations and prevalent mobility difficulty in older women. should the criteria currently used to define anemia in older people be reevaluated? J Am Geriatr Soc 2002; 509: 1257-1264.
25. De Domenico I, Ward DM, Kaplan J. Hepcidin regulation: ironing out the details. J Clin Invest 2007; 117: 1755-1758.
26. Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest 2007; 117: 1933-1939.
27. Katodritou E, Verrou E, Hadjiaggelidou C et al. Erythropoiesis stimulating agents are associated with reduced survival in patients with multiple myeloma. Am J Hematol 2008; 83: 697-701.
28. Paoletti E, Cannella G. Update on erythropoietin treatment: should hemoglobin be normalized in patients with chronic kidney disease? J Am Soc Nephrol 2006; 17: S74-S77.
29. List A, Dewald G, Bennett J et al. Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. N Engl J Med 2006; 355: 1456-1465.
30. Kelaidi C, Eclache V, Fenaux P. The role of lenalidomide in the management of myelodysplasia with del 5q. Br J Haematol 2008; 140: 267-278.
31. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet 2007; 370: 415-426.
32. Moftah F. Blood transfusion and alternatives in elderly, malignancy and chronic disease. Hematology 2005; 10(Suppl 1): 82-85.
33. Swinne C. Heart failure. In: Oxford textbook of geriatric medicine, 2nd edn. Oxford: Oxford University Press, 2000; 417-427.
34. Johnson BD. Age-associated changes in pulmonary reserve. In: Oxford textbook of geriatric medicine, 2nd edn. Oxford: Oxford University Press, 2000; 483-497.
35. Spahn DR, Zollinger A, Schlumpf RB et al. Hemodilution tolerance in elderly patients without known cardiac disease. Anesth Analg 1996; 82: 681-686.
36. Madjdpour C, Spahn DR, Weiskopf RB. Anemia and perioperative red blood cell transfusion: a matter of tolerance. Crit CareMed 2006; 34: S102-108.
37. Hebert PC, Wells G, Laijchmann M et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340: 409-417.
38. Carson JL, Reynolds RC, Klein HG. Bad bad blood? Crit Care Med 2008; 36: 2707-2708.
39. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008; 36: 2667-2674.
40. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 345: 1230-1236.
41. Rao SV, Jollis JG, Harrington RA et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292: 1555-1562.
42. Carson JL, Terrin ML, Barton FB et al. A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion 1998; 38: 522-529.
43. Carson JL, TerrinML, Magaziner J et al. Transfusion trigger trial for functional outcomes in cardiovascular patients undergoing surgical hip fracture repair (FOCUS). Transfusion 2006; 46: 2192-2206.
44. Wieczorowska-Tobis K, Niemir Z, Mossakowska M, Klich-Raczka A. Anemia in centenerians. J Am Geriatr Soc 2002; 50: 1311-1313.